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Infective Endocarditis in Aortic 
Valve Disease
Juan Bustamante-Munguira, Eva María Aguilar Blanco  
and Angels Figuerola-Tejerina
Abstract
Although infective endocarditis is a rare disease, its incidence has increased 
over the last years and, despite improved diagnosis and treatment, it has a poor 
prognosis. The left side is compromised in most cases and underlying valvular heart 
disease is present in a substantial proportion of cases. We review the incidence, 
main clinical features and indications for surgery in left-sided native valve infective 
endocarditis, focusing on the aortic valve.
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1. Introduction
Infective endocarditis (IE) is an infectious disease generally caused by bacteria 
that affect the endocardium, mostly the left chambers. Right-sided endocarditis is a 
different, much less prevalent entity with other clinical and epidemiological charac-
teristics. In this chapter, we analyse left-sided endocarditis, focusing on aortic valve 
involvement to ascertain frequency of presentation, normal signs and symptoms, 
treatment and prognosis. Endocarditis frequently develops on a pathological valve. 
In the western world, the most common valve involvement is aortic sclerosis, that is, 
a certain degree of stenosis from age-associated valve degeneration. It is important 
to point out that aortic stenosis is the most prevalent western-world valvular heart 
disease that requires surgical or interventionist treatment. At 65 years of age, 2–7% 
of the population present some degree of aortic valve sclerosis, and the condition 
progresses over time [1–5].
Infective endocarditis is diagnosed based on modified Duke criteria. Their 
application means that there is an overlap with previously established criteria in 
large series. In addition, the European Society of Cardiology (ESC) in their Clinical 
Practice Guides have recently included some changes with respect to the criteria 
[6, 7], giving more importance to echocardiographic findings and the role of blood 
cultures. These findings are supported by new radiological tests, mainly CT scan, 
F-FDG PET/CT and radiolabelled leucocyte single-photon emission CT (SPECT)/
CT, and there are a major criteria.
The incidence of IE is known to vary according to the series analysed. This 
finding might be due to multiple factors. Various epidemiological cohort studies 
covering prolonged time periods have recently been published, providing key 
updates to clinical and epidemiological knowledge about IE. What is observed in 
these series is an increase in IE incidence, greater comorbidity in the patients and a 
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morbidity-mortality prognosis that has remained substantially the same during the 
last decades in spite of advances in diagnosis and therapy [8].
2. Incidence
As indicated earlier, infective endocarditis (IE) is a rare disease of poor progno-
sis, whose incidence has been growing during the last two decades. Various clinical 
pictures are found within it; fundamentally, it can be divided into endocarditis on 
native valve or prosthesis, and right- or left-sided endocarditis according to location 
[1–5]. Another entity has recently appeared that, due to its frequency and severity, 
is considered separate: health care-associated endocarditis.
Data on the incidence of the disease have been updated in the last few years 
by the publication of various studies of an epidemiological nature. The most 
recent ones report an incidence of 3–10 cases per 100,000 inhabitants/year, but 
there is great geographical variability in the data [1–5, 9]. Over the last few years, 
several groups have published incidences from local studies that give us a geo-
graphical view of the current IE situation. In a study carried out in Spain, Olmos 
et al. observed an increase in incidence, rising from 2.72 cases to 3.49 cases per 
100,000 inhabitants/year during the period analysed (2003–2014) [10]. Likewise, 
Bustamante Munguira et al. reported increased IE incidence in Spain, which rose 
from 3.17% in 1997 to 5.56% in 2014 [9]. In Denmark, Erichsen et al. also observed 
a rise in incidence during 1994–2011, going from 3.93 to 7.55 cases per 100,000 
inhabitants a year [11]. In Italy, Cresti et al. found 4.6 cases per 100,000 during 
the study period 1998–2014 [12]. Representing the Spanish Group Collaboration 
on Endocarditis (Grupo de Apoyo al Manejo de Infective Endocarditis en España, 
GAMES), Muñoz et al. estimated an annual incidence of 3.5 cases per 100,000 
inhabitants during 2008–2012 [13].
The increase in the incidence of the disease is consequently perfectly docu-
mented in the different studies mentioned. One of the motives justifying this 
increase is the appearance of clinical practice-associated endocarditis, as we have 
pointed out. This type of endocarditis is becoming more and more frequent, 
reaching up to 25% depending on the series analysed. Other causes of increased IE 
incidence are population ageing and growth in patient comorbidity. As we indicated 
earlier, associated with ageing of the population, there is an increase in the preva-
lence of valvular heart disease, predominantly in the development of degenerative 
aortic sclerosis and degenerative mitral insufficiency.
Published records from different European countries reveal both increased IE 
incidence and increased fragility and comorbidity in patients presenting IE. In a 
study in France, Hoen et al. reported an incidence of 3.1 cases per 100,000 inhabit-
ants a year [14]. In their study on an English population, Dayer et al. analysed the 
impact that the change in antibiotic prophylaxis recommendations had on the 
incidence of endocarditis in the United Kingdom. Their study results showed that 
IE incidence increased from the start of the study in 2000 until its end in 2013. The 
authors attributed this growth in incidence (as other authors have) to ageing of the 
population, increased comorbidity and the rise in invasive measures associated 
with health care attention. However, they also indicated that one of the determining 
factors in the sample analysed was the change in antibiotic prophylaxis recom-
mendations instituted in March 2008 [15]. In the series reported by Erichsen et al., 
analysing the population in Denmark, incidence rose throughout the study period, 
from 3.93 per 100,000 inhabitants a year in 1994–1996 to 7.55 per 100,000 inhabit-
ants a year in 2009–2011 Table 1.
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These epidemiological studies obtain the information from data in administra-
tive databases gathered when patients are admitted. They are administrative coding 
systems used for management of both public and private hospitals. This method 
makes it possible to analyse broad population samples over long period of time, but 
the fact that it lacks clinical content is a decided weakness. This is the case with the 
Spanish series, in which the minimum basic data set of the National Surveillance 
System for Hospital Data in Spain provided by the Spanish Ministry of Health was 
used [9]. In Italy, Cresti et al. used the Health Care System Hospital Discharge 
Records database with a primary or secondary International Classification of 
Diseases 9th Revision IE diagnosis code [12]. The Danish registry published by 
Reichsen et al. was based on an analysis of the Danish National Patients Registry, 
which was set up in 1968 [11].
The data published in these studies should be interpreted with certain caution, 
given the limitations such analyses have. What is clear, and agreed upon in most 
of the studies, is that the incidence of endocarditis on both native and prosthetic 
valves has increased.
3. Left-sided endocarditis, with aortic compromise
When we analyse valve involvement, we see that endocarditis is found on 
left cavities in 90–95% of the cases, while right-side involvement is rare. Native 
valve endocarditis is far more common (70–80% of the cases) than prosthetic 
Author Country Study period No. of 
patients
Incidence Rate of 
indication for 
surgery
Reference
Bustamante 
Munguira
Spain 1997–2014 34,399 3.17% in 1997 and 
5.56% in 2014
11.7% in 1997 
to 17.8% in 
2014
[8]
Erichsen Denmark 1994–2011 5486 3.93 in 1994–1996 
to 7.55 in 
2009–2011
None [10]
Olmos Spain 2003–2014 16,867 2.72 in 2003 3.49 in 
2014
23% [9]
Fedeli Italy 2000–2008 1873 4.1 in 2000–2002 
to 4.9 in 
2006–2008
23% [15]
Cresti Italy 1998–2014 167 4.6/100,000 46.5% [11]
Hoen France 1999 390 3/100000 49% [13]
Dayer England 1 January 2004 
to 31 March 
2013
19,804 0.11 cases per 10 
million people per 
month
None [14]
Muñoz Spain 1 January 
2008 to 31 
December 
2012
1804 3.5 cases per 
100,000 
inhabitants
44.2% [12]
Ilhão 
Moreira
Portugal 2006 and 2014 233 36.9% [20]
Table 1. 
Main epidemiological studies on endocarditis.
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endocarditis [16]. Multiple valve involvement is infrequent, ranging up to 15–20% 
of the cases according to the series consulted [17].
According to the majority of authors, the frequency of distribution of mitral and 
aortic valve compromise follows a similar proportion. There are almost no studies 
that analyse aortic involvement individually [18]. This is not the case with native 
mitral valve endocarditis; some authors have analysed it independently, alleging 
that the embolism rate is greater and that surgical treatment for these patients can 
be based on valve repair with good short-, medium- and long-term clinical results. 
However, the majority of the studies do not discriminate according to location, 
making a global analysis. Nevertheless, there are certain discrepancies in the studies 
published.
In one of the most numerous series published, with 2781 patients attended in 
58 centres from 25 countries, Murdoch et al. observed that the mitral valve was 
compromised in 41.1% of the cases, while the aortic valve was in 37.6% [19]. In a 
series of 945 consecutive episodes, Olmos et al. found no statistically significant dif-
ferences between the two locations [20], while Muñoz et al. observed that the mitral 
valve was involved in 44.8% of the cases and the aortic in 47.2% [13].
There are discrepancies in the literature. In a French study with 303 patients 
with left-sided endocarditis, Lung et al. found a higher incidence of mitral valve 
compromise than of aortic (49.2 vs. 32.3%) [17]. At the opposite extreme, we find 
the results of the study by Ilhão Moreira et al.; in a series of 233 patients followed 
for 8 years, they observed that aortic involvement was more frequent (55.7%) than 
mitral (38.2%) [21].
As we have pointed out, it is important to remember that endocarditis develops 
on pathological valves in one-fourth of the cases, with valve degeneration being 
the most frequent underlying condition [10, 13, 19]. In some series, this percentage 
is even higher than 35% [12]. It bears repeating that epidemiological aspects are 
important in interpreting study results.
4.  Specific clinical profile of left-sided infective endocarditis with aortic 
valve compromise
Independently of valve involvement, IE presents a shared clinical picture 
characterised by symptoms of systemic infection. Some of these are more frequent 
based on the location involved. The most common symptom is fever, which can 
be present in 90% of the patients. Heart failure is also highly frequent. Associated 
constitutional symptoms, such as weight loss, asthenia and anorexia, are also 
found. There are differences in the percentage of presentation in some of the 
complications.
4.1 Embolism
Aortic valve compromise does not involve embolic risk greater than that of the 
compromise of other valves. Its incidence depends on the size of the vegetation and of 
the microorganism causing the infection. The frequency of embolism in aortic endo-
carditis is, if anything, less than that of mitral endocarditis. Systemic embolism is 
estimated to occur in 22–50% of the cases; most embolisms affect the central nervous 
system, while other locations such as the spleen or kidney are less common [7, 22].
There is a certain variability in the results reported by different authors. 
Vilacosta et al., in a series of 211 patients with left-sided endocarditis, found a 
correlation between vegetation size and embolism for the patients with mitral valve 
endocarditis but not in the case of the aortic valve [23]. However, Hubert et al., in 
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their study analysing 1022 patients, found no correlation with location, but did find 
a statistically significant association with vegetation size [24]. Likewise, in their 
study including 1456 patients, Rizzi et al. found no association with location but did 
find ones with vegetation size and with the causal agent being S. aureus [25].
When the relationship between microorganism and embolism is analysed, it 
can be observed that the results reported are also different according to the series 
considered. Vilacosta et al. indicated that they did not observe any differences 
based on the type of microorganism. This aspect is controversial, given that clinical 
practice guidelines and some authors point out that there is a relationship between 
endocarditis caused by specific microorganisms and the likelihood of developing 
embolic phenomena.
Various risk scores have been developed in relation to this complication for 
calculating the probability of developing embolisms. Among these, the Italian and 
French scales are the most utilised. In a study on 167 patients, Cresti et al. did not 
observe any differences between aortic and mitral locations in the case of native 
valve endocarditis [12]. Hubert et al., in a sample of 1022 patients, likewise found 
no relationship with location; however, they did observe an association with vegeta-
tion size and when the endocarditis was caused by S. aureus [24].
4.2 Atrioventricular block
Aortic valve compromise can progress with symptoms of aortic insufficiency. 
It may trigger heart failure if inception is acute, while other common symptoms 
are embolism and rhythm disorders. Within rhythm alterations, the most frequent 
complication is atrioventricular block from conduction system disruption; its 
incidence ranges from 1 to 15% depending on the series. This complication worsens 
the prognosis, principally because it is the consequence of an annular compromise 
reflecting the extension of the infection. It is more frequent when staphylococci are 
involved. In these cases, it is important to delay the pacemaker implantation and 
always be sure that the infectious process is under control, in order to avoid the risk 
of infection of the pacemaker. There are also differences in the literature as to the 
involvement of the aortic valve compared with the mitral, although some authors 
report similar figures [26].
4.3 Heart failure
Heart failure is the most frequent complication of patients with IE. It is the main 
factor that predicts mortality at 30 days [18]. The presence of heart failure is more 
common when the valve compromise is aortic. The mechanism that explains its 
appearance is the occurrence of valve dysfunction. It is currently the most common 
cause for indicating surgery [27, 28].
5. Indication for surgery in left-sided aortic valve endocarditis
The reported rate for indication for surgery also varies considerably according to 
the studies published. Surgery indication is influenced by the characteristics of the 
centre, which are basically determined by the availability of multidisciplinary teams 
in patient assessment. The range is very wide, going from very low figures of 9.6% 
of the patients with endocarditis [12] up to the rates of indication reported by Lung 
et al. of 73% of the patients attended (with surgery being performed in 46% of the 
cases) [17]. Analysed by location, aortic endocarditis required surgery in 38.2% of 
the cases, when aortic valve compromise was 17% lower.
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Very few authors study surgery of the aortic valve independently of that of the 
mitral valve. The majority of the series combine the two in their analyses, consid-
ering them the same process, left-sided endocarditis. It should be remembered 
that there are some differences between the two locations with respect to clinical 
repercussion, the possibility of generating embolism and the appearance of rhythm 
disorders.
Bustamante Munguira et al., analysing the Spanish series during the time period 
1997–2014, found that the percentage of patients requiring surgery increased over 
the course of the study, reaching 15.7% of the patients [9]. These figures are much 
lower than those of the European registry, in which the Euro Heart Survey reported 
a rate of 58.7% [29]. Once again, the most logical explanation for this finding lies 
in the establishment of protocols for and in the treatment of endocarditis with the 
attention of these patients being given by units of reference.
There are intermediate ranges between these figures. One example is the study 
by Murdoch et al. (with 2781 patients attended in 58 centres in 25 countries), in 
which 48.2% of the patients underwent surgery [19]. In this study, important dif-
ferences based on the type of centre were also observed in the percentage of patients 
that received an indication for surgery, with ranges of 63.4–37.1% (P < 0.001). In 
the series reported by Olmos et al., 23% of the patients required surgery [10]; the 
percentage was greater in the case of the centres with cardiac surgery (35.5%). A 
limitation of this study was that it did not analyse the percentage of aortic patients 
compared with other patients having problems in different locations.
In the study published by Moreira et al. (analysing 233 patients for 8 years), 57% 
of the patients received the indication for surgery, and the patients were operated in 
36.9% of the cases. In that study, the frequency of indication for surgical treatment 
was analysed according to location. It was found that operations were performed in 
64% of the cases of aortic endocarditis, while the percentage was only 31% in the 
cases of mitral endocarditis [21].
6. Conclusions
Infective endocarditis has increased its frequency of appearance as a conse-
quence of ageing of the population and of the number of invasive procedures giving 
rise to the appearance of the condition called health care-associated endocarditis. 
Left-sided cavities are compromised far more frequently than right-sided ones. 
However, there is no clear difference between the percentage of aortic and mitral 
valve involvement. Indications for surgery have gradually increased, but the result 
considered in terms of morbidity-mortality has not improved despite advances in 
techniques and postoperative care. It is hard to find studies in which aortic valve 
compromise is analysed individually, because most studies focus on studying left-
cavity endocarditis and consequently produce a global evaluation.
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